TCI Seminar Series: Christine M. Eischen, PhD | Targeting p53 Mutant Cancer with a Novel PROTAC | In-Person

Name: TCI Seminar Series: Christine M. Eischen, PhD | Targeting p53 Mutant Cancer with a Novel PROTAC | In-Person
Start: 2023-04-04T12:00:00-04:00
End: 2023-04-04T13:00:00-04:00

Christine M. Eischen, PhD

Herbert A. Rosenthal, MD ’56 Professor of Cancer Research

Co-Leader, Immune Cell Regulation and Targeting Program, Sidney Kimmel Cancer Center

Co-Director, Blood Cancer Center of Excellence

Thomas Jefferson University

Tuesday, April 4 at 12:00pm to 1:00pm

Departments: Medicine, Hematology & Medical Oncology, Oncological Sciences
Institutes: The Tisch Cancer Institute

Subscribe

TCI Seminar Series: Christine M. Eischen, PhD | Targeting p53 Mutant Cancer with a Novel PROTAC | In-Person

People Interested